Non-Dilutive Funding Experts
The non-dilutive strategy that makes VCs take notice
We build personalized multi-agency funding portfolios that de-risk your R&D, accelerate your timeline, and turn government grants into your most powerful credibility engine.
Book Strategy Review15-minute call, no obligation. Speak with grant experts.
What we cover in your first call
Estimates for timeline and key risks specific to your technology
Which services fit your stage and goals
High-level eligibility assessment for federal grants
Agency expertise that signals credibility
We know the reviewers, the rhythms, and the strategies that work.
National Science Foundation
Project Pitch to Invite to Proposal. We optimize fit and narrative to earn the invite and set up Phase I/II success.
National Institutes of Health
Omnibus vs. Contract Topics. Clinical significance and commercialization pathways that reviewers expect.
Dept. of Defense
DSIP rhythms. Topic targeting, Q&A etiquette, and Phase III transition planned from day one.
IRAP + SR&ED
Cross-border planning that extends runway without dilution. Maximize both US and Canadian programs.
Why CEOs pick Cada
Portfolio > Proposal
One grant is a gamble. We pursue 3-5 aligned opportunities in parallel across NSF, NIH, DoD, and IRAP/SR&ED.
Speed with compliance
We compress time-to-funding from 12-18 months to 6-9 months. No shortcuts on compliance.
Cross-border leverage
US and Canadian programs in one strategy. Extend your runway without giving up equity on either side of the border.
One grant is a gamble. A portfolio is a strategy.
Most teams chase one grant at a time and wait 6 months for an answer. We pursue 3-5 aligned opportunities in parallel. That's how we compress time-to-funding from 12-18 months to 6-9 months.
- Rolling pipeline: submitting, waiting, revising -- always in play
- Reviewer-first narratives and tight compliance
- Post-award setup to enable Phase II/III
Discovery & strategy
Technology assessment, agency matching, portfolio construction
Writing & submission
Parallel proposals, reviewer-first framing, compliance checks
Agency review
Active monitoring, resubmission strategy, pivot to next opportunity
Awards & negotiation
Budget negotiation, post-award setup, Phase II planning from day one
The credibility effect
What happens when founders stop chasing grants and start building funding portfolios.
NIH SBIR Phase I
Cada didn't just write a proposal. They repositioned our entire technology narrative. The NIH reviewers scored us a 2 on first submission.
NSF SBIR
We went from zero government funding to a $305K NSF Phase I in under 4 months. Our Series A investors specifically cited the grant as a credibility signal.
NSF + IRAP
The cross-border strategy was the unlock. IRAP funded our Canadian R&D while our NSF award covered the US side. No dilution on either.
Book your Strategic Portfolio Review
We'll share a draft 90-day plan mapped to NSF, NIH, DoD, IRAP & SR&ED. 15 minutes. No obligation.
Schedule Now